Cargando…

Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis

BACKGROUNDS: Profiting from the development of nanomaterials, photothermal therapy (PTT) has been discovered as efficient tumor ablation strategy for breast cancer. MATERIALS AND METHODS: Novel oxygen vacancy-rich tungsten bronze nanoparticles (Na(x)WO(3)) were synthesized through a simple pyrogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jie, Shuo, Guo, Xiaoning, Ouyang, Zhengxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750009/
https://www.ncbi.nlm.nih.gov/pubmed/31571856
http://dx.doi.org/10.2147/IJN.S217974
_version_ 1783452388957356032
author Jie, Shuo
Guo, Xiaoning
Ouyang, Zhengxiao
author_facet Jie, Shuo
Guo, Xiaoning
Ouyang, Zhengxiao
author_sort Jie, Shuo
collection PubMed
description BACKGROUNDS: Profiting from the development of nanomaterials, photothermal therapy (PTT) has been discovered as efficient tumor ablation strategy for breast cancer. MATERIALS AND METHODS: Novel oxygen vacancy-rich tungsten bronze nanoparticles (Na(x)WO(3)) were synthesized through a simple pyrogenic decomposition process. TEM, XRD, UV-vis-NIR, photothermal conversion ability, and photothermal stability were performed. The viabilities of 293T and 4T1 cells after treating with 200 μg/mL Na(x)WO(3) nanoparticles for 24 or 48 hrs were both above 80%, which proved the good biosafety and cytotoxicity of Na(x)WO(3) in vitro. Two in vivo breast cancer models, namely percutaneous and intratibial 4T1 models were established and Na(x)WO(3) (20 mg/kg) with power intensity of 1.5 W/cm(2) 980 nm laser photothermal treatment was used in vivo. RESULTS: We successfully synthesized ~150 nm Na(x)WO(3) nanoparticles with desirable PTT effects, as evidenced by the temperature increase from 25.8°C to 41.8°C in 5 mins under the irradiation of 980 nm laser (1 mg/mL). Also, cellular compatibility of Na(x)WO(3) nanoparticles was found upon physiologic 293T cells, in contrast with significant cytotoxicity against breast cancer 4T1 cell in vitro dose-dependently. Besides, two in vivo breast cancer models showed the decent tumor ablation ability of Na(x)WO(3) nanoparticles, demonstrating percutaneous 4T1 tumor elimination without recurrence during 2 weeks observation as well as intratibial breast cancer inhibition with decreased bone destruction and tumor volume after Na(x)WO(3)+PTT in vivo. CONCLUSION: For the first time, we developed a novel oxygen vacancy-rich tungsten bronze nanoparticles (Na(x)WO(3)) through a simple pyrogenic decomposition process for PTT. Both in vitro and in vivo experiments showed the good PTT ability and tumor ablation effects of synthesized Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis. Additionally, our oxygen-deficient Na(x)WO(3) nanoparticles will expand the research horizons of PTT nanomaterials.
format Online
Article
Text
id pubmed-6750009
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67500092019-09-30 Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis Jie, Shuo Guo, Xiaoning Ouyang, Zhengxiao Int J Nanomedicine Original Research BACKGROUNDS: Profiting from the development of nanomaterials, photothermal therapy (PTT) has been discovered as efficient tumor ablation strategy for breast cancer. MATERIALS AND METHODS: Novel oxygen vacancy-rich tungsten bronze nanoparticles (Na(x)WO(3)) were synthesized through a simple pyrogenic decomposition process. TEM, XRD, UV-vis-NIR, photothermal conversion ability, and photothermal stability were performed. The viabilities of 293T and 4T1 cells after treating with 200 μg/mL Na(x)WO(3) nanoparticles for 24 or 48 hrs were both above 80%, which proved the good biosafety and cytotoxicity of Na(x)WO(3) in vitro. Two in vivo breast cancer models, namely percutaneous and intratibial 4T1 models were established and Na(x)WO(3) (20 mg/kg) with power intensity of 1.5 W/cm(2) 980 nm laser photothermal treatment was used in vivo. RESULTS: We successfully synthesized ~150 nm Na(x)WO(3) nanoparticles with desirable PTT effects, as evidenced by the temperature increase from 25.8°C to 41.8°C in 5 mins under the irradiation of 980 nm laser (1 mg/mL). Also, cellular compatibility of Na(x)WO(3) nanoparticles was found upon physiologic 293T cells, in contrast with significant cytotoxicity against breast cancer 4T1 cell in vitro dose-dependently. Besides, two in vivo breast cancer models showed the decent tumor ablation ability of Na(x)WO(3) nanoparticles, demonstrating percutaneous 4T1 tumor elimination without recurrence during 2 weeks observation as well as intratibial breast cancer inhibition with decreased bone destruction and tumor volume after Na(x)WO(3)+PTT in vivo. CONCLUSION: For the first time, we developed a novel oxygen vacancy-rich tungsten bronze nanoparticles (Na(x)WO(3)) through a simple pyrogenic decomposition process for PTT. Both in vitro and in vivo experiments showed the good PTT ability and tumor ablation effects of synthesized Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis. Additionally, our oxygen-deficient Na(x)WO(3) nanoparticles will expand the research horizons of PTT nanomaterials. Dove 2019-09-09 /pmc/articles/PMC6750009/ /pubmed/31571856 http://dx.doi.org/10.2147/IJN.S217974 Text en © 2019 Jie et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jie, Shuo
Guo, Xiaoning
Ouyang, Zhengxiao
Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis
title Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis
title_full Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis
title_fullStr Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis
title_full_unstemmed Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis
title_short Tumor ablation using novel photothermal Na(x)WO(3) nanoparticles against breast cancer osteolytic bone metastasis
title_sort tumor ablation using novel photothermal na(x)wo(3) nanoparticles against breast cancer osteolytic bone metastasis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750009/
https://www.ncbi.nlm.nih.gov/pubmed/31571856
http://dx.doi.org/10.2147/IJN.S217974
work_keys_str_mv AT jieshuo tumorablationusingnovelphotothermalnaxwo3nanoparticlesagainstbreastcancerosteolyticbonemetastasis
AT guoxiaoning tumorablationusingnovelphotothermalnaxwo3nanoparticlesagainstbreastcancerosteolyticbonemetastasis
AT ouyangzhengxiao tumorablationusingnovelphotothermalnaxwo3nanoparticlesagainstbreastcancerosteolyticbonemetastasis